Label: MESSIMA EX- phellinus linteus mycelium powder

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated February 27, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    phellinus linteus mycelium
  • INACTIVE INGREDIENT

    a-Methyl-D(+)-Glucoside
  • PURPOSE

    - effective in uterine discharge and bleeding, dysmenorrheal, intestinal bleeding and activation of GI system
    -improving the immune functions of cancer patients after surgical resection of stomach, colon, or liver
  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children
  • INDICATIONS & USAGE

    - effective in uterine discharge and bleeding, dysmenorrheal, intestinal bleeding, and activation of GI system, 550-1100mg twice a day before meals
    - effective in improving the immune functions of cancer patients after surgical resection of stomach, colon, or liver, 1100mg three times a day before meals
  • WARNINGS

    - GI system:  may cause nausea, vomiting, diarrhea, or abdominal discomfort
    - dizziness (one case), headache (one case), and constipation (three cases) were reported during clinical trials
  • DOSAGE & ADMINISTRATION

    for oral use only
  • PRINCIPAL DISPLAY PANEL

    package insert
  • INGREDIENTS AND APPEARANCE
    MESSIMA EX 
    phellinus linteus mycelium powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53144-2001
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PHELLINUS LINTEUS MYCELIUM (UNII: 40K19XJV3C) (PHELLINUS LINTEUS MYCELIUM - UNII:40K19XJV3C) PHELLINUS LINTEUS MYCELIUM1.1 g  in 1.1 g
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE (UNII: J2B2A4N98G)  
    ICODEXTRIN (UNII: 2NX48Z0A9G)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53144-2001-11.1 g in 1 PACKAGE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other12/29/2012
    Labeler - Yein Trading & Global Co., Ltd (557803795)
    Registrant - Yein Trading & Global Co., Ltd (557803795)
    Establishment
    NameAddressID/FEIBusiness Operations
    Han Kook Sin Yak Pharmaceutical Co., Ltd.689277536manufacture(53144-2001)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!